Legal Opinion
Walgreen Co. v. Organon, Inc.
District Court, D. New Jersey
Decided September 8, 2004No. Nos. 02-2007 (FSH), 03-0085(FSH), 03-222(FSH), 03-5488(FSH)PublishedCited by 7 opinions
1Opinion of the Court
OPINION
HOCHBERG, District Judge.
INTRODUCTION
This matter comes before the Court upon Defendants Organon USA Inc. and Akzo Nobel N.V.’s (collectively “Organon”) consolidated motion to dismiss Plaintiffs’ antitrust claims pursuant to Fed.R.Civ.P. 12(b)(6). The Court has considered the written submissions of the parties pursuant to Fed.R.Civ.P. 78.
BACKGROUND
Organon ■ manufactures the antidepressant drug mirtazapine', commercially marketed as Remeron, which was originally claimed in its now-expired United States Patent No. 4,062,848 (the “ ’848 patent”). Adding its patent and regulatory…
2Cases cited30 opinions
- In Re Burlington Coat Factory Securities Litigation. P. Gregory Buchanan, Jacob Turner and Ronald AbramoffCourt of Appeals for the Third Circuit · 1997
- Montana v. United StatesSupreme Court of the United States · 1979
- United States v. Grinnell Corp.Supreme Court of the United States · 1966
- Brunswick Corp. v. Pueblo Bowl-O-Mat, Inc.Supreme Court of the United States · 1977
- Arizona v. CaliforniaSupreme Court of the United States · 1983
25 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- In Re Ciprofloxacin Hydrochloride Antitrust LitigationDistrict Court, E.D. New York · 2005
- Molecular Diagnostics Laboratories v. Hoffmann-La Roche Inc.District Court, District of Columbia · 2005
- In Re Remeron Antitrust LitigationDistrict Court, D. New Jersey · 2007
- Meijer, Inc. v. Ferring B.V.Court of Appeals for the Second Circuit · 2009
- In re Lantus Direct Purchaser Antitrust LitigationDistrict Court, D. Massachusetts · 2018
2 more not listed; retrieve them via the Exa API.